Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

ALX Oncology (NASDAQ:ALXO) stock fell 16% Thursday after the company reported updated data from a Phase 2 study called ASPEN-06 for its drug candidate evorpacept. ALX said the data showed evorpacept ...

David M. Waterhouse, MD, MPH, and Molly Mendenhall, MBOE, LSSBB, BSN, RN, discuss how the implementation of Lean Six Sigma methodology at Oncology Hematology Care in Cincinnati, Ohio, has transformed ...

Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

Predictive Oncology Inc (POAI) stock saw a modest uptick, ending the day at $1.48 which represents a slight increase of $0.21 or 16.54% from the prior close of $1.27. The stock opened at $1.58 and ...

Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is ...

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

A French cohort study confirmed high risks for lymphoma and small bowel cancer in patients with celiac disease but also found elevated risks for pancreatic, esophageal, gastric and colonic cancers ...

Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...